Results 221 to 230 of about 21,694,421 (382)

ShcD adaptor protein drives invasion of triple negative breast cancer cells by aberrant activation of EGFR signaling

Molecular Oncology, EarlyView.
We identified adaptor protein ShcD as upregulated in triple‐negative breast cancer and found its expression to be correlated with reduced patient survival and increased invasion in cell models. Using a proteomic screen, we identified novel ShcD binding partners involved in EGFR signaling pathways.
Hayley R. Lau, Hayley S. Smith, Begüm Alural, Claire E. Martin, Laura A. New, Manali Tilak, Sara L. Banerjee, Hannah N. Robeson, Nicolas Bisson, Anne‐Claude Gingras, Jasmin Lalonde, Nina Jones   +11 more
wiley   +1 more source

Behavioral DiverCity: individual differences in behavior change along an urbanization gradient. [PDF]

Behav Ecol
Gervais L, Thompson MJ, de Villemereuil P, Burkhard T, Teplitsky C, Class B, Réale D, Charmantier A.   +7 more
europepmc   +1 more source

Stylistic Components of Human Judgment: The Generality of Individual Differences

, 1977
Nerella V. Ramanaiah, Lewis R. Goldberg
openalex   +2 more sources

Targeting the AKT/mTOR pathway attenuates the metastatic potential of colorectal carcinoma circulating tumor cells in a murine xenotransplantation model

Molecular Oncology, EarlyView.
Dual targeting of AKT and mTOR using MK2206 and RAD001 reduces tumor burden in an intracardiac colon cancer circulating tumor cell xenotransplantation model. Analysis of AKT isoform‐specific knockdowns in CTC‐MCC‐41 reveals differentially regulated proteins and phospho‐proteins by liquid chromatography coupled mass spectrometry. Circulating tumor cells
Daniel J. Smit, Thais Pereira‐Veiga, Helena Brauer, Michael Horn, Paula Nissen, Thomas Mair, Bente Siebels, Hannah Voß, Ruimeng Zhuang, Marie‐Therese Haider, Desiree Loreth, Margarita Iskhakova, Bele Lindemann, Julian Kött, Laure Cayrefourcq, Jasmin Wellbrock, Hartmut Schlüter, Klaus Pantel, Catherine Alix‐Panabières, Manfred Jücker   +19 more
wiley   +1 more source

Reflecting on Dunbar's numbers: Individual differences in energy allocation to personal relationships. [PDF]

PLoS One
Li W, Lee DS, Stahl JL, Bayer J.
europepmc   +1 more source

Time, the final frontier

Molecular Oncology, EarlyView.
This article advocates integrating temporal dynamics into cancer research. Rather than relying on static snapshots, researchers should increasingly consider adopting dynamic methods—such as live imaging, temporal omics, and liquid biopsies—to track how tumors evolve over time.
Gautier Follain, Michal Dibus, Omkar Joshi, Guillaume Jacquemet   +3 more
wiley   +1 more source

Individual differences in the evolution of causal illusions. [PDF]

Br J Psychol
García-Arch J, Rodríguez-Ferreiro J, Barberia I.   +2 more
europepmc   +1 more source

AN APPROACH TO THE PROBLEM OF INTER-INDIVIDUAL DIFFERENCES IN THE LEVEL OF ASPIRATION BEHAVIOR OF CRIPPLED CHILDREN : ON ROLES OF THE "SOCIAL PSYCHOLOGICAL VARIABLES"

, 1971
Teruo Kurihara
openalex   +2 more sources

Inhibitor of DNA binding‐1 is a key regulator of cancer cell vasculogenic mimicry

Molecular Oncology, EarlyView.
Elevated expression of transcriptional regulator inhibitor of DNA binding 1 (ID1) promoted cancer cell‐mediated vasculogenic mimicry (VM) through regulation of pro‐angiogenic and pro‐cancerous genes (e.g. VE‐cadherin (CDH5), TIE2, MMP9, DKK1). Higher ID1 expression also increased metastases to the lung and the liver.
Emma J. Thompson, Emma L. Dorward, Kristyn Jurrius, Nathalie Nataren, Markus Tondl, Kay K. Myo Min, Michaelia P. Cockshell, Anahita Fouladzadeh, John Toubia, Mark DeNichilo, Delphine Merino, Claudine S. Bonder   +11 more
wiley   +1 more source

Neural basis for individual differences in the attention-enhancing effects of methylphenidate. [PDF]

Proc Natl Acad Sci U S A
Manza P, Tomasi D, Demiral ŞB, Shokri-Kojori E, Lildharrie C, Lin E, Wang GJ, Volkow ND.   +7 more
europepmc   +1 more source